MOLECULAR AND GENETIC FEATURES OF COAGULATION DISORDERS IN PATIENT WITH GOUT

Authors

  • Akramova Nigora Turdikulovna 1 st year PhD student at Tashkent medical academy
  • DS, Professor Nabiyeva Dildora Abdumalikovna Head of the faculty and hospital treatment, occupational diseases
  • Aditya Kush 1 st year medical student at Tashkent medical academy, international department
  • Ibragimova Dilfuza Narzikulovna Samarkand State Medical Institute
  • Akramov Iskandar Rahmonkulovich Tashkent medical academy

Keywords:

Molecular, Genetic, Gout, Coagulation

Abstract

Gout is a rheumatic disease characterized by hyperuricemia. It causes recurrent attacks of inflammation, pain, disability, and discomfort due to the accumulation of urate crystals in the joints, caused by overproduction or underexcretion of uric acid. Recent studies have shown that gout patients are prone to cardiovascular disease, including coagulation disorders like PE and DVT. The paper aims to summarize the possible link between gout and coagulation disorders by studying the molecular and genetic features of gout patients

References

Messerli, F.H., E.D. Frohlich, G.R. Dreslinski, D.H. Suarez and G.G. Aristimuno, 1980. Serum uric acid in essential hypertension: An indication of renal vascular involvement. Ann. Intern. Med., 93: 817-821.

Grahame, R. and J.T. Scott, 1970. Clinical survey of 352 pateints with gout. Ann. Rheum. Dis., 29: 461-468.

Lieber, C.S., D.P. Jones, M.S. Losowsky and C.S. Davidson, 1962. Interrelation of uric acid and ethanol metabolism in man. J. Clin. Invest., 41: 1863-1870.

PubMed

Darlington, L.G. and J.T. Scott, 1972. Plasma lipid levels in gout. Ann. Rheum. Dis., 31: 487-489.

Feldman, E.B. and S.L. Wallace, 1964. Hypertriglyceridemia in gout. Circulation, 29: 508-513.

Darlington, L.G., J. Slack and J.T. Scott, 1982. Family study of lipid and purine levels in gout patients. Ann. Rheum. Dis., 41: 253-256.

Viozzi, Frank J.; Bluhm, Gilbert B.; and Riddle, Jeanne M. (1972) "Gout and Arterial Thrombosis," Henry Ford Hospital Medical Journal : Vol. 20 : No. 3 , 119-124. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol20/iss3/1

Gilbert B. Bluhm, Jeanne M. Riddle,Platelets and vascular disease in gout, Seminars in Arthritis and Rheumatism,Volume 2, Issue 4,1973,Pages 355-366,ISSN 0049-0172,https://doi.org/10.1016/0049-0172(73)90023-1.

D.J.C. Ramsey, S. Cotton, E.S. Lawrence, M.J. Semple, P.F. Worth, A. Petrie, T.W. Stone and L.G. Darlington, 2005. Clotting Factors in Patients with Acute and Chronic Gout. Journal of Medical Sciences, 5: 47-1.DOI: 10.3923/jms.2005.47.51 URL: https://scialert.net/abstract/?doi=jms.2005.47.51

MUSTARD JF, MURPHY EA, OGRYZLO MA, SMYTHE HA. BLOOD COAGULATION AND PLATELET ECONOMY IN SUBJECTS WITH PRIMARY GOUT. Can Med Assoc J. 1963 Dec 14;89(24):1207-11. PMID: 14084698; PMCID: PMC1922159.

Daisy Vedder1,2 · Martijn Gerritsen1 · Joost C. M. Meijers3,4 · Michael T. Nurmohamed1,2,5 Coagulation in gout: is there a link with disease activity? Clinical Rheumatology (2022) 41:1809–1815 https://doi.org/10.1007/s10067-022-06047-9pro

Richard J. Johnson, Duk-Hee Kang, Daniel Feig, Salah Kivlighn, John Kanellis, Susumu Watanabe,

Katherine R. Tuttle, Bernardo Rodriguez-Iturbe, Jaime Herrera-Acosta, Marilda Mazzali. Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? (Hypertension. 2003;41:1183-1190.) http://ahajournals.org by on February 2, 2023

Guo, Y, Zhou, F, Xu, H. Gout and risk of venous thromboembolism: A systematic review and meta-analysis of cohort studies. Int J Rheum Dis. 2023; 26: 344- 353. doi:10.1111/1756-185X.14524

Kruchinova, S.; Shvartz, V.; Namitokov, A.; Gendugova, M.; Karibova, M.; Kosmacheva, E. Prevalence of Polymorphisms of Genes Responsible for Coagulation System and Folate Metabolism and Their Predictive Value for Thrombosis Development in MINOCA Patients: Immediate and Long-Term Prognoses. Cardiogenetics 2023, 13, 47-60. https://doi.org/10.3390/cardiogenetics13020006

Coburn BW, Mikuls TR. Treatment Options for Acute Gout. Fed Pract. 2016 Jan;33(1):35-40. PMID: 30766136; PMCID: PMC6366613.

Michael H. Pillinger, Brian F. Mandell,Therapeutic approaches in the treatment of gout,Seminars in Arthritis and Rheumatism,Volume 50, Issue 3, Supplement, 2020,Pages S24-S30,ISSN 0049-0172, https://doi.org/10.1016/j.semarthrit.2020.04.010.

Lisa K. Stamp, Peter T. Chapman, Gout and its comorbidities: implications for therapy, Rheumatology, Volume 52, Issue 1, January 2013, Pages 34–44, https://doi.org/10.1093/rheumatology/kes211

Downloads

Published

2023-06-12

How to Cite

Akramova Nigora Turdikulovna, DS, Professor Nabiyeva Dildora Abdumalikovna, Aditya Kush, Ibragimova Dilfuza Narzikulovna, & Akramov Iskandar Rahmonkulovich. (2023). MOLECULAR AND GENETIC FEATURES OF COAGULATION DISORDERS IN PATIENT WITH GOUT. World Bulletin of Public Health, 23, 77-80. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/2890

Issue

Vol. 23 (2023): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.